Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
Non-adherence to daily drug regimens is responsible for many negative clinical effects including drug resistance in life-long treatments for HIV. Here, the authors report on a HIV prodrug nanoparticle platform for long-acting sustained release of water-soluble drug compounds following injection.
Guardado en:
Autores principales: | James J. Hobson, Amer Al-khouja, Paul Curley, David Meyers, Charles Flexner, Marco Siccardi, Andrew Owen, Caren Freel Meyers, Steve P. Rannard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0af90520fd9449aa84b2d09b2855e9b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim IM, et al.
Publicado: (2019) -
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
por: Rahul P. Bakshi, et al.
Publicado: (2018) -
Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
por: Hana Bavlovič Piskáčková, et al.
Publicado: (2021) -
Aspects of cost analysis in semi-solid state processing
por: Adrian Constantin Tanasie
Publicado: (2021) -
The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
por: Frank KJ, et al.
Publicado: (2012)